Skip to main content
Premium Trial:

Request an Annual Quote

Consortium Seeks Next-Gen Sequencing Providers for Second Phase of Atlantic Salmon Genome Project

Premium

The International Cooperation to Sequence the Atlantic Salmon Genome is seeking sequencing providers for the second phase of the project, which will primarily use next-generation sequencing technologies.

Last year, the consortium, which involves researchers, funding agencies, and industry representatives from Canada, Chile, and Norway, awarded a $6 million contract to Beckman Coulter Genomics for the first phase of the project. The firm is sequencing the salmon genome at four-fold coverage using paired-end, plasmid, fosmid, and BAC Sanger sequencing (IS 12/15/2009), and this phase is expected to be completed by January 2011.

ICSASG is now looking for genome sequencing centers or public-private partnerships interested in providing sequencing for the second phase, which will result in a "high-definition, well-annotated" genome. This phase will use "primarily" next-generation sequencing technologies.

Interested parties should contact ICSASG and will be invited to a workshop in Toronto in September "to present an approach to accomplishing the goal." After that, ICSASG will publish a formal request for proposals.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.